Nomograms for drug use in renal disease

Clinical Pharmacokinetics
P Chennavasin, D C Brater

Abstract

The medical literature is replete with dosing guidelines for patients with renal dysfunction. Altering dosing regimens in such patients is particularly important with drugs with a narrow therapeutic index, such as digoxin and the aminoglycoside antibiotics. A variety of methods have been used to devise dosing nomograms. This article reviews the salient features of different methods, and addresses the issues of predictability or unpredictability in attaining desired plasma concentrations of drug. It is suggested that therapy must be individualised, and that the clinician can best plan his therapy by understanding the principles on which dose adjustment is based, rather than using the same nomogram or guideline for each and every patient.

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·I Janků
Jan 1, 1982·European Journal of Clinical Pharmacology·P Chennavasin, D C Brater
Jan 1, 1993·European Journal of Clinical Pharmacology·I Janků
Mar 27, 2001·Transplantation Proceedings·A P van den BergP L Jansen
Jan 1, 1986·European Journal of Clinical Pharmacology·R van DalenE Termond
Aug 5, 2010·Wiener klinische Wochenschrift·Sebastian MausBertram Hartmann
Nov 1, 1983·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W M BennettI Singer
Jan 15, 2014·Journal of Clinical Pharmacology·Raphaël VlavonouMario Tanguay
Jan 1, 1983·Journal of Chronic Diseases·G R Wilkinson
Mar 1, 1982·Journal of Clinical and Hospital Pharmacy·W L Chiou
May 1, 1986·Acta paediatrica Scandinavica·L Gortner, D Hellenbrecht
Jul 25, 2009·Clinical Pharmacology and Therapeutics·D C Brater
Apr 1, 1983·Drug Intelligence & Clinical Pharmacy·T B VreeR van Dalen
Feb 1, 1983·Drug Intelligence & Clinical Pharmacy·D R Guay
Apr 1, 1984·Australian and New Zealand Journal of Medicine·P C Ho, E J Triggs
Jun 1, 1983·Drug Intelligence & Clinical Pharmacy·G R MatzkeR L Lucarotti
Dec 1, 1990·DICP : the Annals of Pharmacotherapy·C L Smith, E M Hampton
May 1, 1986·Annals of Clinical Biochemistry·R B Payne
Oct 21, 2010·Deutsches Ärzteblatt International·Bertram HartmannFrieder Keller
Nov 1, 1992·Critical Reviews in Oncology/hematology·G Daugaard, U Abildgaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.